These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16599303)

  • 21. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Acute bacterial prostatitis in Korea.
    Etienne M; Caron F
    Int J Antimicrob Agents; 2009 Aug; 34(2):185-6. PubMed ID: 19342203
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.
    Rossolini GM; Dryden MS; Kozlov RS; Quintana A; Flamm RK; Läuffer JM; Lee E; Morrissey I; CLASS Study Group
    J Antimicrob Chemother; 2011 Jan; 66(1):151-9. PubMed ID: 21051375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004-2010.
    Hawser SP; Bouchillon SK; Hackel M; Chen M; Kim EC
    Int J Antimicrob Agents; 2012 Jun; 39(6):490-5. PubMed ID: 22534507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
    Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
    Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.
    Tubau F; Liñares J; Rodríguez MD; Cercenado E; Aldea MJ; González-Romo F; Torroba L; Berdonces P; Plazas J; Aguilar L; Delgado A; García-Escribano N;
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):308-13. PubMed ID: 20022193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic sensitivity of microorganisms, isolated from patients with opportunistic infections].
    Tymchyk OV; Shapiro AV; Vasylenko OH
    Mikrobiol Z; 2005; 67(5):64-8. PubMed ID: 16396113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; López F; Alvarez J; Picazo JJ;
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteraemia in a tertiary care urban hospital in south India.
    Chaudhury A; Rao TV
    Indian J Pathol Microbiol; 1999 Jul; 42(3):317-20. PubMed ID: 10862291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
    Balode A; Punda-Polić V; Dowzicky MJ
    Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
    Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system.
    Ullberg M; Özenci V
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):139-149. PubMed ID: 31641972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the BD Phoenix Automated Microbiology System for identification and antimicrobial susceptibility testing of common clinical isolates.
    Liu ZK; Ling TK; Cheng AF
    Med Princ Pract; 2005; 14(4):250-4. PubMed ID: 15961935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance analysis of bacterial strains isolated from burn patients.
    Wang LF; Li JL; Ma WH; Li JY
    Genet Mol Res; 2014 Jan; 13(4):9727-34. PubMed ID: 24535909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
    Shahum A; Benca G; Duong LS; Augustin A; Havlik S; Liska A; Kalavsky E; Beno P; Krcmery V
    J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens.
    Amsler K; Santoro C; Foleno B; Bush K; Flamm R
    J Clin Microbiol; 2010 Sep; 48(9):3353-7. PubMed ID: 20592149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.